The document discusses the potential of GPCR signaling in drug discovery and the development of water-soluble protein replicants. It highlights the applications in various diseases, research tools, diagnostics, and therapeutics. The company OH2 is structured to monetize these technologies across multiple fields, with a focus on GPCR-related pharmaceuticals.
documents/EFTA01113695.pdf
{}